- Presentations
- 6
- Markets
- 1
Retacrit is a brand of Epoetin marketed by Pfizer Laboratories, with 6 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Epoetin
- Brand owner
- Pfizer Laboratories
- Registered in
- United States
- Strengths and forms
- 10000 IU/mL injection, 2000 IU/mL injection, 20000 IU/mL injection, 3000 IU/mL injection, 4000 IU/mL injection, 40000 IU/mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Retacrit 10000 IU/mL injectionIntravenous, subcutaneous Cold chain | Pfizer Laboratories | US FDA | Available on request |
| Retacrit 2000 IU/mL injectionIntravenous, subcutaneous Cold chain | Pfizer Laboratories | US FDA | Available on request |
| Retacrit 20000 IU/mL injectionIntravenous, subcutaneous Cold chain | Pfizer Laboratories | US FDA | Available on request |
| Retacrit 3000 IU/mL injectionIntravenous, subcutaneous Cold chain | Pfizer Laboratories | US FDA | Available on request |
| Retacrit 4000 IU/mL injectionIntravenous, subcutaneous Cold chain | Pfizer Laboratories | US FDA | Available on request |
| Retacrit 40000 IU/mL injectionIntravenous, subcutaneous Cold chain | Pfizer Laboratories | US FDA | Available on request |
Equivalent brands
Other brands of Epoetin.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Retacrit
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.